Adenovirus Quantitative Real-time PCR
Some specimen types for this assay are reported as qualitative results; please see our Specimen Information section below for more information.
Adenovirus is an important cause of morbidity and mortality in the transplant setting, causing pneumonia, hemorrhagic cystitis, hepatitis, encephalitis, pancreatitis, enteritis, and disseminated disease with the mortality rate reaching 60% in some especially high risk situations such as pediatric hematopoietic stem cell transplantation. Since proper management is dependent upon early diagnosis, quantitative adenovirus DNA PCR is useful for detecting the virus, tracking the course of infection, and monitoring response to treatment. Treatment of adenovirus in immunocompromised patients presents challenges, including drug toxicity, delayed onset of disease after discontinuing therapy, and emergence of mutations that may affect the ability of diagnostic assays to detect them efficiently.
About Adenovirus
Severe morbidity and mortality due to adenovirus infection affect both hematopoietic stem cell transplant and solid organ transplant recipients.1 Common illnesses due to adenovirus infection include hemorrhagic cystitis/nephritis, pneumonitis, hepatitis, liver failure, and gastroenteritis, particularly during the acute post-transplant period prior to engraftment. Symptoms of adenovirus infection vary widely, depending on the organ involved. Adenovirus nephritis is associated with acute renal failure in 90% of infected patients.2 Also, adenovirus infection is associated with graft-versus-host-disease (GvHD) and allograft failures.1
ProcedureExtraction of adenovirus DNA from specimen followed by amplification and detection of known adenovirus strains using real-time, quantitative PCR. An internal control is added to ensure the extraction was performed correctly and the PCR reaction was not inhibited. Sequence polymorphisms in the assay target region can cause impaired primer or probe binding, which may result in significant under-quantification or a false negative result. To eliminate this possibility, Viracor’s Adenovirus qPCR assay targets two regions within the pathogen genome, utilizing unique primer and probe sets for each target site. When a polymorphism occurs in one assay target, the additional sets of primers and probes for the alternate target region will still detect and accurately quantify the pathogen, and thus reduces the likelihood of under-qualification or a false negative result. This test was developed and its performance characteristics determined by Eurofins Viracor. It has not been cleared or approved by the U.S. Food and Drug Administration.
SpecificityDetects all known serotypes in one assay. The primers and probes used in this assay are specific for known adenovirus strains based on similarity search algorithms. Additionally, no cross reactivity was detected when tested against BKV, CMV, EBV, HSV-1, HSV-2, HHV-6 variant A, HHV-6 variant B, HHV-7, HHV-8, JCV, Parvovirus B19, SV-40, and VZV.
Same day (within 8 - 12 hours from receipt of specimen), Monday through Saturday, with the exception of Tissue and Bone Marrow specimens. Tissue and Bone Marrow specimens are expected to report within 18-24 hours from receipt of specimen, Monday-Saturday.
Specimen Type | Test Code | CPT Code | NY Approved | Volume | Assay Range | Special Instructions |
---|---|---|---|---|---|---|
plasma | 7501 | 87799 | Yes | 2 mL (min. 0.5 mL) |
190 copies/mL to 1x1010 copies/mL |
|
urine | 7502 | 87799 | Yes | 2 mL (min. 0.5 mL) |
152 copies/mL to 1x1010 copies/mL |
|
CSF | 7503 | 87799 | Yes | 2 mL (min. 0.5 mL) |
109 copies/mL to 1x1010 copies/mL |
|
bone marrow | 7504 | 87799 | Yes | 2 mL (min. 0.2 mL) |
589 copies/mL to 1x1010 copies/mL |
|
Fresh Frozen Tissue [Quant] | 7505 | 87799 | Yes | 5 mg fresh tissue (approximately ½ of a pencil eraser size) | 13 copies/mL to 1x1010 copies/mL |
|
Fresh Frozen Tissue [Qual] | 7506 | 87798 | Yes | 5 mg fresh tissue (approximately ½ of a pencil eraser size) | Detected/Not Detected |
|
fecal [Quant] | 7538 | 87799 | Yes | Size of pea, or 2 mL liquid stool |
1500 copies/g to 1.25E+11 copies/g |
|
fecal [Qual] | 7508 | 87798 | Yes | Size of pea, or 2 mL liquid stool |
Detected/Not Detected |
|
BAL | 7509 | 87799 | Yes | 2 mL (min. 0.5 mL) |
38 copies/mL to 1x1010 copies/mL |
|
serum | 7510 | 87799 | Yes | 2 mL (min. 0.5 mL) |
190 copies/mL to 1x1010 copies/mL |
|
pleural fluid | 7511 | 87799 | Yes | 2 mL (min. 0.5 mL) |
157 copies/mL to 1x1010 copies/mL |
|
pericardial fluid | 7512 | 87799 | Yes | 2 mL (min. 0.5 mL) |
157 copies/mL to 1x1010 copies/mL |
|
nasal wash | 7513 | 87799 | Yes | 2 mL (min. 0.5 mL) |
54 copies/mL to 1x1010 copies/mL |
|
trach asp | 7519 | 87799 | Yes | 2 mL (min. 0.5 mL) |
38 copies/mL to 1x1010 copies/mL |
|
throat gargle | 7523 | 87799 | Yes | 2 mL (min. 0.5 mL) |
54 copies/mL to 1x1010 copies/mL |
|
NP aspirate | 7524 | 87799 | Yes | 2 mL (min. 0.5 mL) |
54 copies/mL to 1x1010 copies/mL |
|
NP swab | 7525 | 87798 | Yes | 2 mL |
Detected/Not Detected |
|
bronch wash | 7526 | 87799 | Yes | 2 mL (min. 0.5 mL) |
38 copies/mL to 1x1010 copies/mL |
|
nasal swab | 7530 | 87798 | Yes | 2 mL |
Detected/Not Detected |
|
nasal asp | 7531 | 87799 | Yes | 2 mL (min. 0.5 mL) |
54 copies/mL to 1x1010 copies/mL |
|
NP wash | 7547 | 87799 | Yes | 2 mL (min. 0.5 mL) |
54 copies/mL to 1x1010 copies/mL |
|
trach wash | 7548 | 87799 | Yes | 2 mL (min. 0.5 mL) |
38 copies/mL to 1x1010 copies/mL |
|
Ship Monday through Friday. Friday shipments must be labeled for Saturday delivery. All specimens must be labeled with patient's name and collection date. A Eurofins Viracor test requisition form must accompany each specimen. Multiple tests can be run on one specimen. Ship specimens FedEx Priority Overnight® to: Eurofins Viracor, 18000 W 99th St. Ste, #10, Lenexa, KS 66219
Causes for RejectionWood shafted swab, calcium alginate swab, specimens received in trap containers, grossly hemolyzed plasma/serum specimens, specimens beyond their acceptable length of time from collection as listed in the specimen handling, or specimen types other than those listed.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Eurofins Viracor's interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Eurofins Viracor assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.
References1 Echavarria M. Adenoviruses in immunocompromised hosts. Clin Microbial Rev. Oct 2008;21(4):704-15.
2 Robin M, Marque-Juillet S, Scieux C, et al. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica. Sep 2007;92(9):1254-7.